Trastuzumab-associated cardiac events in the Persephone trial

<h4>Background</h4> <p>We report cardiac events in the Persephone trial which compares 6–12 months of adjuvant trastuzumab in women with confirmed HER2-positive, early-stage breast cancer.</p> <h4>Methods</h4> <p>Clinical cardiac events were defined as any...

Full description

Bibliographic Details
Main Authors:	Earl, H, Vallier, A, Dunn, J, Loi, S, Ogburn, E, McAdam, K, Hughes-Davies, L, Harnett, A, Abraham, J, Wardley, A, Cameron, D, Miles, D, Gounaris, I, Plummer, C, Hiller, L
Format:	Journal article
Published:	Nature Publishing Group 2016

Trastuzumab-associated cardiac events in the Persephone trial

Similar Items